INVESTOR ALERT: Kaplan Fox Investigates Potential Securities Fraud at Clover Health Investments Corp. Kaplan Fox & Kilsheimer LLP
NEW YORK, Feb. 05, 2021 (GLOBE NEWSWIRE) Kaplan Fox & Kilsheimer LLP (
www.kaplanfox.com) is investigating claims on behalf of investors of Clover Health Investments Corp. (“Clover” or the “Company”) (NASDAQ: CLOV).
On February 4, 2021, Hindenburg Research published a report about Clover entitled Clover Health: How the King of SPACs Lured Retail Investors Into a Broken Business Facing an Active, Undisclosed DOJ Investigation. The report claims Clover has not disclosed that its business model and its software offering, called the Clover Assistant, are under active investigation by the Department of Justice, which is investigating at least 12 issues ranging from kickbacks to marketing practices to undisclosed third-party deals. The report also accuses billionaire Chamath Palihapitiya of misleading investors of critical aspects of Cl
Share this article
Share this article
SAN DIEGO, Feb. 5, 2021 /PRNewswire/ Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of the federal securities laws by Clover Health Investments, Corp. ( Clover Health or the Company ) (NASDAQ: CLOV).
On January 7, 2021, Clover Health merged with SPAC Social Capital Hedosophia Holdings Corp. III (NYSE: IPOC) and began to trade under the symbol CLOV.
On February 4, 2021,
Hindenburg Research issued a report titled Clover Health: How the King of SPACs Lured Retail Investors Into a Broken Business Facing an Active, Undisclosed DOJ Investigation. Hindenburg Research detailed a series of alarming red flags about Clover Health. Specifically, the report stated that Clover has not disclosed that its business model and its software offering, called the Clover Assistant, are under active investigation by the Department of Justice (DOJ), which is investigating at least 12 issues ranging from kickbacks
Press release content from Business Wire. The AP news staff was not involved in its creation.
Federman & Sherwood Investigates Clover Health Investments, Corp. for Possible Violations of Federal Securities Laws
February 5, 2021 GMT
OKLAHOMA CITY (BUSINESS WIRE) Feb 5, 2021
The law firm of Federman & Sherwood has initiated an investigation into Clover Health Investments, Corp [NASDAQ: CLOV] with respect to possible violations of federal securities laws.
On January 7, 2021, Clover Health Investments, Corp. (“CLOV”) merged with SPAC Social Capital Hedosphia Holdings Corp. III and began to trade under the symbol CLOV. On February 4, 2021, Hindenburg Research published a report about CLOV titled “Clover Health: How the “King of SPACs” Lured Retail Investors Into a Broken Business Facing an Active, Undisclosed DOJ Investigation.” The report alleged that Clover “has not disclosed that its business model and its software offering, called the Clover Assistant, are under ac